Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia

Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia

US Patent 11459313 · Granted Oct 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of extracellular signal-regulated kinase2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-he2023
Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors2023
Treatment agents for inhibiting HIV and cancer in HIV infected patients2022
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2021
Reversal of fosfomycin resistance2021
Small molecule lipid II inhibitors2021
Small molecule lipid II inhibitors2021
Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof2020
Certain compounds, compositions and methods2017
Inhibitors of D-amino acid oxidase2016